A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/565 (2006.01) A61K 31/57 (2006.01) A61P 15/00 (2006.01) A61P 15/12 (2006.01) A61P 15/18 (2006.01)
Patent
CA 2666829
The invention relates to the use of estradiol valerate or estradiol in combination with 17a-cyanomethyl-17-.beta.-hydroxyestra-4,9-dien-3-one (dienogest) in a multiphase or single-phase combination preparation for oral therapy for maintaining and/or increasing the female libido, optionally also in unity with oral contraception. The total daily dose units of the multiphase combination and of the pharmaceutically acceptable placebo or of the single-phase combination and the active-ingredient-free and placebo-free daily dose units correspond to 28 days.
L'invention concerne l'utilisation de valérate d'AEstradiol ou d'AEstradiol en combinaison avec de la 17.alpha.-cyanométhyl-17.beta.-hydroxyAEstra-4,9-dién-3-one (Diénogest) dans une préparation mixte multiphasique ou monophasique destinée à la thérapie orale de maintien et/ou d'augmentation de la libido féminine, le cas échéant associée également à une contraception orale. Les unités de doses journalières totales de la combinaison multiphasique et du placebo pharmaceutiquement neutre ou de la combinaison monophasique et des unités de doses journalières sans principe actif et sans placebo correspondent à 28 jours.
Parke Susanne
Zeun Susan
Zimmermann Holger
Bayer Pharma Aktiengesellschaft
Bayer Schering Pharma Aktiengesellschaft
Marks & Clerk
LandOfFree
Use of estradiol valerate or 17.beta.-estradiol in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of estradiol valerate or 17.beta.-estradiol in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of estradiol valerate or 17.beta.-estradiol in... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1761436